AdaptHealth Q2 net revenue $793M (+9% YoY), net income flat $14M; Adj. EBITDA $171M (+14%); FY guidance narrowed

AdaptHealth Corp.

2023-Q2 EPS reported $0.03 revenue$1,537,912,000

Net revenue $793.3M, +9.0% YoY; non-acquired net revenue growth 8.7%.
Net income attributable $14.0M (flat YoY); Adjusted EBITDA $171.0M (+14.0%).
Year-to-date cash flow from ops $226.6M (up from $169.9M); free cash flow $54.8M (up from $15.6M).
FY2023 guidance narrowed: net revenue $3.16-3.20B (prior $3.16-3.24B); Adj. EBITDA $650-680M (prior $650-710M).
Planned CEO transition: Crispin Teufel to join as CEO in September 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

AdaptHealth Corp. reported the second quarter ended June 30, 2023 results: revenue $793.3 million, net income $14.0 million. Guidance lowered.

Period: the second quarter ended June 30, 2023
Revenue: $793.3 million
Net income: $14.0 million
Guidance: lowered
Result: reported results

Exact text from the filing

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2023. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2022 unless otherwise stated. • Net revenue was $793.3 million compared to $727.6 million, an increase of 9.0% . ◦ Non-acquired net revenue growth was 8.7%. • Net income attributable to AdaptHealth Corp. was $14.0 million, compared to $14.0 million.

View on SEC.gov

18 earnings releases filed in the last 30 days. Browse all earnings releases →

AdaptHealth Corp. filing history →

Source: SEC EDGAR

accession 0001628280-23-027927

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.